Journal
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Volume 89, Issue 9, Pages 962-969Publisher
BMJ PUBLISHING GROUP
DOI: 10.1136/jnnp-2017-316988
Keywords
-
Categories
Funding
- Wellcome Trust Intermediate Clinical Fellowship [097479/Z/11/Z]
- Wellcome Beit Prize fellowship [097479/Z/11/A]
- European Union's Horizon 2020 research and innovation programme [116060]
- ARUK
- BMA
- Oxford Biomedical Research Centre
- EPSRC [EP/M006204/1]
- Wellcome Trust [097479/Z/11/A, 097479/Z/11/Z] Funding Source: Wellcome Trust
Ask authors/readers for more resources
In our ageing population, neurodegenerative disorders carry an enormous personal, societal and economic burden. Although neurodegenerative diseases are often thought of as clinicopathological entities, increasing evidence suggests a considerable overlap in the molecular underpinnings of their pathogenesis. Such overlapping biological processes include the handling of misfolded proteins, defective organelle trafficking, RNA processing, synaptic health and neuroinflammation. Collectively but in different proportions, these biological processes in neurons or non-neuronal cells lead to regionally distinct patterns of neuronal vulnerability and progression of pathology that could explain the disease symptomology. With the advent of patient-derived cellular models and novel genetic manipulation tools, we are now able to interrogate this commonality despite the cellular complexity of the brain in order to develop novel therapeutic strategies to prevent or arrest neurodegeneration. Here, we describe broadly these concepts and their relevance across neurodegenerative diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available